Caution with Use of the EPIC-50 Urinary Bother Scale: How Voiding Dysfunction Modifies its Performance
Abstract
Purpose:
We evaluated agreement between patient reported urinary function and bother, and sexual function and bother in patients treated with radical prostatectomy to help inform possible nonfunctional, modifiable mechanisms for patient bother.
Materials and Methods:
Patients were recruited from 2011 to 2014 at Washington University, and Brigham and Women’s Hospital. Urinary and sexual outcomes were assessed by EPIC-50 (Expanded Prostate Cancer Index Composite-50) before, 5 weeks and 12 months after radical prostatectomy. Spearman rank correlation coefficients and agreement/disagreement categories were used to describe the relation between function and bother.
Results:
Despite moderate to good agreement between function and bother (urinary r = 0.51–0.69 and sexual r = 0.65–0.80) discordant groups were observed. In the urinary domain these groups were men disproportionately bothered by function at baseline (16.9%) and 12 months after radical prostatectomy (6.1%) and men less bothered by function 5 weeks (26.8%) and 12 months (9.9%) after radical prostatectomy. Discordant groups in the sexual domain were men less bothered by function at baseline (20.8%), and 5 weeks (21.1%) and 12 months (15.7%) after radical prostatectomy. Splitting the urinary bother scale into 2 subscales, including one for incontinence related bother to complement the urinary function scale which measures only incontinence, and one for voiding dysfunction related bother yielded considerably better agreement (urinary function and incontinence related bother r = 0.78–0.83). Factors contributing to the group less bothered by sexual function were unclear.
Conclusions:
When using EPIC-50, investigators should consider splitting the urinary bother scale by the relation to incontinence to prevent distortions of function-bother and comparisons before vs after radical prostatectomy by coexisting voiding dysfunction.
References
- 1 : Global cancer statistics, 2012. CA Cancer J Clin2015; 65: 87. Google Scholar
- 2 : Quality of life and prostate cancer treatment. J Urol1999; 162: 407. Link, Google Scholar
- 3 : Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med2008; 358: 1250. Google Scholar
- 4 : Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials. J Natl Cancer Inst2014; 106. Google Scholar
- 5 : “We used a validated questionnaire”: what does this mean and is it an accurate statement in urologic research?. Urology2015; 85: 1304. Google Scholar
- 6 : Determinants of long-term sexual health outcome after radical prostatectomy measured by a validated instrument. J Urol2003; 169: 1453. Link, Google Scholar
- 7 : Prospective quality-of-life outcomes for low-risk prostate cancer: active surveillance versus radical prostatectomy. Cancer2015; 121: 2465. Google Scholar
- 8 : Patient-perceived satisfaction after definitive treatment for men with high-risk prostate cancer: radical prostatectomy vs. intensity-modulated radiotherapy with androgen deprivation therapy. Urology2015; 85: 407. Google Scholar
- 9 : Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology2000; 56: 899. Google Scholar
- 10 : Prospective assessment of time-dependent changes in quality of life of Japanese patients with prostate cancer following robot-assisted radical prostatectomy. J Robot Surg2016; 10: 201. Google Scholar
- 11 : Five year expanded prostate cancer index composite-based quality of life outcomes after prostatectomy for localized prostate cancer. BJU Int2011; 107: 585. Google Scholar
- 12 : Health-related quality of life using SF-8 and EPIC questionnaires after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy. Jpn J Clin Oncol2009; 39: 502. Google Scholar
- 13 : Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys2008; 72: 421. Google Scholar
- 14 : Prospective health-related quality-of-life assessment in an initial cohort of patients undergoing robotic radical prostatectomy. Urology2006; 68: 1061. Google Scholar
- 15 : Prospective and longitudinal patient self-assessment of health-related quality of life following radical perineal prostatectomy. J Urol2004; 172: 264. Link, Google Scholar
- 16 : Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form. Urology2015; 85: 101. Google Scholar
- 17 : Comparison of distribution- and anchor-based approaches to infer changes in health-related quality of life of prostate cancer survivors. Health Serv Res2012; 47: 1902. Google Scholar
- 18 : Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors. Urology2010; 76: 1245. Google Scholar
- 19 Vertosick EA, Vickers AJ, Cowan JE et al: Interpreting patient reported urinary and sexual function outcomes across multiple validated instruments. J Urol, suppl., 197: e1239, abstract MP93-08. Google Scholar
- 20 : Benign prostatic hyperplasia and lower urinary tract symptoms. N Engl J Med2012; 367: 1668. Google Scholar
- 21 : A narrative review of patient-reported outcomes in overactive bladder: what is the way of the future?. Eur Urol2016; 70: 799. Google Scholar
- 22 : Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy. Prostate Cancer Prostatic Dis2016; 19: 132. Google Scholar
- 23 : Are we targeting the right outcome for sexual health after prostate cancer treatment?. Eur Urol2015; 68: 550. Google Scholar
- 24 : Urinary bother as a predictor of postsurgical changes in urinary function after robotic radical prostatectomy. Urology2015; 86: 817. Google Scholar
- 25 : Relief of urinary symptom burden after primary prostate cancer treatment. J Urol2016; 197: 376. Google Scholar
- 26 : Overactive bladder and storage lower urinary tract symptoms following radical prostatectomy. Urology2016; 94: 193. Google Scholar
- 27 : Short-, intermediate-, and long-term quality of life outcomes following radical prostatectomy for clinically localized prostate cancer. Rev Urol2013; 15: 161. Google Scholar
- 28 : Psychological aspects of prostate cancer: a clinical review. Prostate Cancer Prostatic Dis2012; 15: 120. Google Scholar
- 29 : The effects of a presurgical stress management intervention for men with prostate cancer undergoing radical prostatectomy. J Clin Oncol2009; 27: 3169. Google Scholar
- 30 Klein EA: Radical prostatectomy for localized prostate cancer. UpToDate®, April 1, 2010. Available at https://www.uptodate.com/contents/radical-prostatectomy-for-localized-prostate-cancer. Accessed February 7, 2017. Google Scholar
